ClinicalTrials.Veeva

Menu

Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media

Wyeth logo

Wyeth

Status

Completed

Conditions

Otitis Media With Effusion
Otitis Media
Pneumococcal Infections

Treatments

Drug: Prevenar

Study type

Observational

Funder types

Industry

Identifiers

NCT00195611
0887X-100918

Details and patient eligibility

About

The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.

Enrollment

3,293 patients

Sex

All

Ages

6 to 24 months old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Infants aged from 6 to 24 months
  • Presenting with AOM (ear infection)
  • Patients must not have received any antibiotic therapy within the past 7 days.

Other inclusion applies.

Exclusion Criteria:

Trial contacts and locations

35

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems